Baird Medical Investment Holdings Limited (BDMD)

NASDAQ: BDMD · Real-Time Price · USD
1.780
-0.030 (-1.66%)
Dec 26, 2024, 4:00 PM EST - Market closed
-1.66%
Market Cap 63.69M
Revenue (ttm) 33.05M
Net Income (ttm) 12.55M
Shares Out 35.78M
EPS (ttm) 0.43
PE Ratio 4.17
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,893
Open 1.860
Previous Close 1.810
Day's Range 1.780 - 1.910
52-Week Range 1.420 - 13.520
Beta 0.09
Analysts n/a
Price Target n/a
Earnings Date n/a

About BDMD

Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company’s medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2012
Employees 148
Stock Exchange NASDAQ
Ticker Symbol BDMD
Full Company Profile

Financial Performance

In 2023, BDMD's revenue was $31.46 million, a decrease of -10.35% compared to the previous year's $35.09 million. Earnings were $10.55 million, a decrease of -16.09%.

Financial numbers in USD Financial Statements

News

Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment

NEW YORK , Dec. 23, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in N...

3 days ago - PRNewsWire

Baird Medical Sponsored and Participated in 2024 Guangdong Thyroid Surgery Committee Annual Meeting

NEW YORK , Dec. 17, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive medical technologies, proudly sponsored and participated in the 2024 Guangdong Thyroid Surgery Com...

9 days ago - PRNewsWire

Baird-Sponsored Microwave Ablation Training Advances Innovation in Thyroid Care

NEW YORK , Dec. 16, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in N...

10 days ago - PRNewsWire

Baird Medical Charts 2025 Strategic Vision Following Milestone Year

NEW YORK , Dec. 10, 2024 /PRNewswire/ -- Baird Medical Group (NASDAQ: BDMD), a leader in minimally invasive medical technologies, recently convened its 2024 Annual Review and 2025 Planning Meeting at ...

16 days ago - PRNewsWire

Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China

NEW YORK , Nov. 25, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a global leader in minimally invasive microwave ablation (MWA) technology, proudly sponsored and participated in the 2024 7th Thy...

4 weeks ago - PRNewsWire

Baird Medical Showcased Microwave Ablation Technology at Massachusetts Society of Otolaryngology Event

NEW YORK , Nov. 11, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in microwave ablation technology, proudly participated in the recent Massachusetts Society of Otolaryngology (MSO) event...

6 weeks ago - PRNewsWire

Baird Medical's Advanced Microwave Ablation Solutions Captivate Attendees at the 2024 ATA Meeting

NEW YORK , Nov. 4, 2024 /PRNewswire/ -- Baird Medical (Nasdaq: BDMD), a leader in minimally invasive microwave ablation (MWA) technology, proudly participated in the 2024 American Thyroid Association ...

7 weeks ago - PRNewsWire

Baird Medical Advances Global Academic Collaboration in Thyroid Health

NEW YORK , Oct. 28, 2024 /PRNewswire/ -- From October 24-27, Baird Medical proudly invited and gathered leading experts from the U.S. and China to advance the field of thyroid care through a series of...

2 months ago - PRNewsWire

Baird Medical Proudly Invited to Showcase Microwave Ablation Technology at the ACS Clinical Congress

NEW YORK , Oct. 24, 2024 /PRNewswire/ -- Baird Medical, (NASDAQ: BDMD) a global leader in minimally invasive microwave ablation (MWA) technology, successfully participated in the prestigious 2024 Amer...

2 months ago - PRNewsWire

Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting

NEW YORK , Oct. 14, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading developer and provider of microwave ablation ("MWA") medica...

2 months ago - PRNewsWire

Baird Medical Announces Preliminary Financial Results for the Six Months Ended June 30, 2024

Total revenues increased to US$13.1 million, representing 13.8% year-over-year growth Net income reached US$4.4 million, representing 85.8% year-over-year growth GUANGZHOU, China , Oct. 11, 2024 /PRNe...

2 months ago - PRNewsWire

Baird Medical Lists in the U.S. on the Nasdaq Exchange

Company Rings Opening Bell to Celebrate Closure of Business Combination and Begins Journey as a Public Company; Shares trade under "BDMD" Ticker FORT MILL, S.C. , Oct. 9, 2024 /PRNewswire/ -- Baird Me...

2 months ago - PRNewsWire

Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference

GUANGZHOU, China , Oct. 8, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer ...

2 months ago - PRNewsWire

Baird Medical and ExcelFin Acquisition Corp Complete Business Combination

NEW YORK , Oct. 1, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in Ch...

3 months ago - PRNewsWire

Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement

FORT MILL, S.C. , Sept. 5, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provid...

4 months ago - PRNewsWire

Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders

Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a $12.50 trading price Minimum cash condition of $15 million has been waived, cementing certainty a...

10 months ago - PRNewsWire

ExcelFin Acquisition Corp. Announces Adjournment of Special Meeting

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- ExcelFin Acquisition Corp. ("we", "us", "our", or the "Company"), today announced that the Special Meeting originally scheduled for October 18, 2023 (the "Speci...

1 year ago - PRNewsWire

Baird Medical, A Leading Developer and Provider of Microwave Ablation (MWA) Medical Devices in China, to be Publicly Listed on NASDAQ through a Proposed Business Combination with ExcelFin Acquisition Corp.

Ranked first among MWA medical device providers in thyroid nodule and breast lump treatment with approximately 35% market share in China [1] Extensive distribution network with over 430 hospitals pene...

1 year ago - PRNewsWire

ExcelFin Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 13, 2021

SAN FRANCISCO, Dec. 15, 2021 /PRNewswire/ -- ExcelFin Acquisition Corp. (Nasdaq: XFIN) (the "Company") announced today that commencing December 13, 2021, holders of the units sold in the Company's ini...

3 years ago - PRNewsWire